Provecho Pharma Private Limited
About Provecho Pharma Private Limited
Data last updated:
Provecho Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC171163. Its GSTIN is 27AAJCP2720Q1ZY (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Suhas Chintaman Joshi and Vivek Vidyadhar Londhe.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Shop No. 3 Anandshilpa Society 1523 Sadashiv Peth, Pune, Maharashtra, India – 411030.
As per the financials filed for FY 2022, the company reported a revenue of ₹40.08 Lakh, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹14.05 Lakh (net margin -35.1%) and EBITDA of -₹12.48 Lakh (EBITDA margin -31.1%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Provecho Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 3 Anandshilpa Society 1523 Sadashiv Peth, Pune, Maharashtra, India – 411030
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Provecho Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Provecho Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Provecho Pharma Private Limited, buy the company report.
Financials of Provecho Pharma Private Limited
FY 2022 filings availableProvecho Pharma Private Limited reported revenue of ₹40.08 Lakh (up 30% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 30% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 13%. EBITDA fell 303% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹40.08 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12.48 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -31.1% | ||||
| Net Profit Margin | -35.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Provecho Pharma Private Limited, buy the company report.
Board of directors of Provecho Pharma Private Limited
Provecho Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suhas Chintaman Joshi Also directs: Provecho Medi Venture LLP | Director | 27 Jun 2017 | 9 Years 4 Months | Current |
| Vivek Vidyadhar Londhe | Director | 27 Jun 2017 | 9 Years 4 Months | Current |
Auditor
Provecho Pharma Private Limited is audited by B S & CO LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S & CO LLP | FY 2022 | W100072 |
Shareholding
The shareholding of Provecho Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Provecho Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Provecho Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Provecho Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Provecho Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCP2720Q1ZY | Maharashtra | Active | 28 Aug 2017 |
To see the full GST registrations and return filing status of Provecho Pharma Private Limited, buy the company report.
Recent activity
Provecho Pharma Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Adwait Vinayak Sathe ceased to be Director on 18 Apr 2024.
Frequently asked questions
Provecho Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 June 2017 (9+ years old) and is registered under CIN U74999PN2017PTC171163.
Provecho Pharma has 2 current directors:
- Suhas Chintaman Joshi - Director
- Vivek Vidyadhar Londhe - Director
The latest financial statements of Provecho Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Provecho Pharma is 27AAJCP2720Q1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Provecho Pharma is U74999PN2017PTC171163. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Provecho Pharma was incorporated on 27 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
Adwait Vinayak Sathe ceased to be Director on 18 Apr 2024. Suhas Chintaman Joshi was appointed as Director on 27 Jun 2017. Vivek Vidyadhar Londhe was appointed as Director on 27 Jun 2017.
The registered office of Provecho Pharma is at Shop No. 3 Anandshilpa Society 1523 Sadashiv Peth, Pune, Maharashtra, India – 411030.
Provecho Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Provecho Pharma is compliant as of 14 September 2026. The company is actively filing with the Registrar of Companies.